Eko Analysis Software vs Tempus ECG-AF
AI Verdict
Choose Eko Analysis Software if…
Choose Eko Analysis Software if your clinical workflow involves real-time auscultation and you need immediate AI-powered assistance for detecting current heart murmurs or atrial fibrillation at the point of care. This tool is ideal for clinicians seeking to enhance their physical exams with digital stethoscope integration, recording capabilities, and remote monitoring features for proactive patient management.
View Eko Analysis Software →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your primary goal is to proactively identify elderly patients (65+) at increased risk of developing new-onset atrial fibrillation within the next 12 months, leveraging existing 12-lead ECG data. This solution is best suited for integrating into cardiology or geriatrics workflows to stratify risk and guide earlier follow-up for preventative interventions.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Analysis Software | Tempus ECG-AF |
|---|---|---|
| Pricing | Unknown | Contact vendor |
| Deployment | Unknown | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Analysis SoftwareEko Analysis Software integrates with digital stethoscopes and a mobile app, offering direct, point-of-care interaction for clinicians with features like recording, playback, and visualization designed for intuitive use. In contrast, Tempus ECG-AF operates as a backend software solution without a dedicated user interface, integrating primarily through APIs with existing healthcare facility systems.
Clinical Value
Eko Analysis SoftwareBoth tools are FDA-cleared and clinically validated. Eko Analysis Software provides immediate diagnostic support for multiple conditions, including heart murmurs, AFib, and Low EF, at the point of care with high sensitivity and specificity. Tempus ECG-AF offers predictive risk for new-onset AF within 12 months, which is valuable for proactive follow-up, but its sensitivity for detecting new AF is lower, and it is not intended for diagnosis.
Pricing & Value
Tempus ECG-AFEko Analysis Software offers a freemium model with transparent subscription tiers for full features, providing a clear entry point. Tempus ECG-AF, while requiring direct vendor contact for pricing, has established CMS reimbursement (CPT 0764T and CPT 0765T with a Medicare rate of $128.90), which offers a significant and clear financial value proposition for healthcare facilities.
Enterprise Readiness
Tempus ECG-AFTempus ECG-AF is designed for deep integration into existing healthcare facility systems, explicitly supporting compatibility with major 12-lead ECG vendors (GE, Philips) and leveraging EHR integrations via standard communication protocols like APIs. While Eko also targets enterprises with its cloud-based platform, Tempus's focus on seamless integration with established hospital IT infrastructure and workflows gives it an edge in enterprise readiness.
Innovation
TieEko Analysis Software innovates by bringing AI-powered diagnostics to the point of care through digital stethoscopes, enhancing the traditional physical exam with real-time detection of multiple cardiac conditions. Tempus ECG-AF innovates by applying AI to existing 12-lead ECG data for predictive risk stratification of new-onset AF, enabling proactive patient management and earlier intervention. Both represent significant advancements in their respective approaches to cardiovascular care.
Support & Docs
Eko Analysis SoftwareEko provides a comprehensive and clearly outlined support system, including a Help Center with FAQs and user manuals, email, phone, and chat support, along with live Q&A sessions and 1:1 calls. Tempus's support information for ECG-AF is less detailed, primarily directing users to a general email or local representative for their broader AI offerings.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Analysis Software | Tempus ECG-AF |
|---|---|---|
| Name | Eko Analysis Software | Tempus ECG-AF |
| Company | Eko Devices | Tempus AI, Inc. |
| Description | FDA-cleared AI-powered tool that integrates with Eko's digital stethoscopes and mobile app to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation. | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. |
| Key Detections | FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, Detection of normal sinus rhythm, Calculation of cardiac time intervals (heart rate, QRS duration) | AI-based algorithm for 12-lead ECG analysis, Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months |
| Target Patient Population | Adults (> 18 years) | Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery |
| Input Data | Heart sounds and ECGs from Eko's digital stethoscopes | 12-lead ECG recordings from GE Medical Systems and Philips Medical Systems |
Videos
Demos, reviews, and walkthroughs featuring Eko Analysis Software and Tempus ECG-AF.